Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Most Accessed Articles
Ponatinib: A Review of Efficacy and Safety
, 2018; 18(9): 847-856.Fulvio Massaro, Matteo Molica and Massimo Breccia*
DOI: 10.2174/1568009617666171002142659
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
, 2018; 18(9): 857-868.Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour
DOI: 10.2174/1568009618666180102102311
Parp Inhibitors for the Treatment of Ovarian Cancer
, 2018; 18(9): 877-893.Laura Cortesi, Angela Toss* and Iole Cucinotto
DOI: 10.2174/1568009618666180308104646
Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
, 2016; 16(3): 226-237.Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
DOI: 10.2174/1568009616666151113120705
The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells
, 2018; 18(10): 988-998.Lei Zheng and Jingxuan Pan*
DOI: 10.2174/1568009618666180425142653
Role of MicroRNAs in Treatment Response in Prostate Cancer
, 2018; 18(10): 929-944.Anshuli Razdan, Paul de Souza* and Tara Laurine Roberts
DOI: 10.2174/1568009618666180315160125
p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents
, 2018; 18(8): 749-772.Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra
DOI: 10.2174/1568009617666170623111953
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
, 2003; 3(1): 1-19.R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden
DOI: 10.2174/1568009033333754
Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
, 2015; 15(6): 452-462.Saїd C. Azoury, David M. Straughan and Vivek Shukla
DOI: 10.2174/156800961506150805145120
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net